RATIONALE: An orientation and patient education program and telephone counseling may help improve the quality of life in patients with peritoneal surface malignancies.
PURPOSE: This clinical trial studies quality of life and survivorship care in patients undergoing surgery and chemotherapy for peritoneal surface malignancies.
|First Received Date||May 13, 2010|
|Last Changed Date||July 2, 2018|
|Start Date||May 2010|
|Actual Primary Completion Date||April 2011|
|Primary Outcome Measures||
Assess feasibility of instituting an orientation program, brief follow up care and phone calls in this patient population [Time Frame: Baseline to 3 months post discharge]
|Secondary Outcome Measures||
Reduce pre-treatment distress and anxiety [Time Frame: Pre-HIPEC to Day 0]
Improve pre-treatment self-efficacy [Time Frame: Pre-HIPEC to Day 0]
Provide educational material delivered by the SRB [Time Frame: Pre-HIPEC to Day 0]
Improve overall post-operative QOL ratings at 3 months, relative to discharge [Time Frame: 3 months post discharge]
|Study Arms / Comparison Groups||1 / 0|
I. Assess feasibility of instituting an orientation program, brief follow up care and phone calls in this patient population.
I. Reduce pre-treatment distress and anxiety. II. Improve pre-treatment self-efficacy. III. Provide educational material delivered by the SRB. IV. Improve overall post-operative QOL ratings at 3 months, relative to discharge.
Patients and their caregiver(s) receive a hyperthermic intraperitoneal chemotherapy (HIPEC) orientation with a Survivorship Navigator (SN) over 90 minutes following their initial surgical consult. Patients then receive telephone calls over 20-30 minutes from the SN once weekly for 3 weeks prior to HIPEC. . After HIPEC, patients meet with the SN for 20-30 minutes to discuss adjustments and adaptation to the surgery and hospitalization 3-4 days post-HIPEC, biweekly for two weeks, and weekly thereafter until hospital discharge. After hospital discharge, patients receive telephone calls from the SN twice monthly for 1 month.
|Ages||N/A - N/A|
|Accepts Healthy Volunteers||No|
- Patients who undergo CS and HIPEC for peritoneal surface malignancy
|Sponsor||Wake Forest University Health Sciences|
|Verification Date||July 2018|